Clinical Trials Logo

Clinical Trial Summary

In this study, the investigator will try to highlight the presence of carbonyl compounds in the hair follicles of postpartum women by comparing these compounds before and after delivery.


Clinical Trial Description

At the cutaneous level, oxidative stress induces the formation of carbonyl compounds which, by binding to proteins, produce non-functional adducts inducing cutaneous aging. This mechanism is called "carbonyl stress".

During pregnancy, estrogen increases massively, stimulates the whole body and prolongs the life of the hair (slower passage in telogen phase).

After delivery, estrogen levels drop, resulting in a massive and simultaneous hair loss that should have "naturally" fallen earlier. In addition, birth is a stressful stage for most moms. This stress and excessive fatigue and possibly a return to work may also be responsible for hair loss.

Is the carbonyl stress also present in the scalp and can it be one of the mechanisms involved in the occurrence of postpartum hair loss? To demonstrate this, samples of hair follicles are taken. The proteins are extracted from the samples and then assayed. The oxidized (carbonyl) proteins are labeled with specific fluorescent probes ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04237402
Study type Interventional
Source Pierre Fabre Dermo Cosmetique
Contact
Status Completed
Phase N/A
Start date June 15, 2018
Completion date December 16, 2019

See also
  Status Clinical Trial Phase
Completed NCT03272750 - Evaluation of Tolerance and Trichological Efficacy of a Food Supplement N/A
Terminated NCT02548689 - PAI-1 Expression in Non-scarring Hair Loss
Recruiting NCT04834102 - COVID-19 Induced Telogen Effluvium
Not yet recruiting NCT04880889 - BL3000 Compared to Pantogar® in the Treatment of Telogen Effluvium in Women. Phase 3
Completed NCT04652232 - Efficacy Study of Cosmetic Product Against Telogen Effluvium on Women N/A
Completed NCT04450602 - A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss N/A
Completed NCT04450589 - A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Male Subjects With Hair Loss N/A